BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31055889)

  • 1. Role of Oxidative Stress in Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma.
    Aydın Yaz Y; Yıldırım N; Yaz Y; Tekin N; İnal M; Şahin FM
    Turk J Ophthalmol; 2019 Apr; 49(2):61-67. PubMed ID: 31055889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smell Sensitivity in Primary Open-angle Glaucoma and Pseudoexfoliation Glaucoma.
    Dikmetas O; Aygün O; Kocabeyoglu S; Süslü AE; Kilic B; Karakaya J; Iester M; Irkec M
    J Glaucoma; 2022 May; 31(5):300-304. PubMed ID: 35180155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prooxidant-antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma.
    Koliakos GG; Befani CD; Mikropoulos D; Ziakas NG; Konstas AG
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1477-83. PubMed ID: 18607617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide and tumour necrosis factor alpha in the process of pseudoexfoliation glaucoma.
    Sarenac Vulovic TS; Pavlovic SM; Jakovljevic VLj; Janicijevic KB; Zdravkovic NS
    Int J Ophthalmol; 2016; 9(8):1138-42. PubMed ID: 27588268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T allele of lysyl oxidase-like 1 rs41435250 is a novel risk factor for pseudoexfoliation syndrome and pseudoexfoliation glaucoma independently and through intragenic epistatic interaction.
    Guadarrama-Vallejo D; Miranda-Duarte A; Zenteno JC
    Mol Vis; 2013; 19():1937-44. PubMed ID: 24068861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of high-risk alleles in the LOXL1 gene and its association with pseudoexfoliation syndrome and exfoliation glaucoma in a Latin American population.
    Jaimes M; Rivera-Parra D; Miranda-Duarte A; Valdés G; Zenteno JC
    Ophthalmic Genet; 2012 Mar; 33(1):12-7. PubMed ID: 21970694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three Single Nucleotide Polymorphisms of
    Yaz Y; Yıldırım N; Aydın Yaz Y; Çilingir O; Yüksel Z; Mutlu F
    Turk J Ophthalmol; 2018 Oct; 48(5):215-220. PubMed ID: 30405941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrobulbar hemodynamics and aqueous humor levels of endothelin-1 in exfoliation syndrome and exfoliation glaucoma.
    Koukoula SC; Katsanos A; Tentes IK; Labiris G; Kozobolis VP
    Clin Ophthalmol; 2018; 12():1199-1204. PubMed ID: 29997432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Lysyl Oxidase-Like 1 Gene Polymorphisms in Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma in a Spanish Population.
    de Juan-Marcos L; Escudero-Domínguez FA; Hernández-Galilea E; Cabrillo-Estévez L; Cruz-González F; Cieza-Borrella C; Sánchez-Barba M; González-Sarmiento R
    Ophthalmic Genet; 2016; 37(1):25-30. PubMed ID: 24892565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of developing atherosclerosis in pseudoexfoliation glaucoma.
    Janićijević K; Kocić S; Pajović S; Zdravković N; Šarenac-Vulović T; Janićijević-Petrović M
    Vojnosanit Pregl; 2017 Jan; 74(1):8-12. PubMed ID: 29350499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optic nerve head vessel density in patients with pseudoexfoliation syndrome/glaucoma: A systematic review and meta-analysis.
    Sener H; Polat OA; Gunay Sener AB
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103514. PubMed ID: 36933675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of
    Taghavi E; Daneshvar R; Noormohammadi Z; Modarresi SM; Sedaghat MR
    Iran J Public Health; 2019 Oct; 48(10):1827-1837. PubMed ID: 31850260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic high-sensitivity C-reactive protein level in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
    Yüksel N; Pirhan D; Altintaş O; Cağlar Y
    J Glaucoma; 2010 Aug; 19(6):373-6. PubMed ID: 19855290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese.
    Lee KY; Ho SL; Thalamuthu A; Venkatraman A; Venkataraman D; Pek DC; Aung T; Vithana EN
    Mol Vis; 2009 Jun; 15():1120-6. PubMed ID: 19503743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum heparan sulfate and chondroitin sulfate concentrations in patients with newly diagnosed exfoliative glaucoma.
    Maric VD; Bozic MM; Cirkovic AM; Stankovic SD; Marjanovic IS; Grgurevic AD
    PeerJ; 2019; 7():e6920. PubMed ID: 31198625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of eNOS G894T Gene Polymorphism in Patients with Pseudoexfoliation Syndrome: A Preliminary Study.
    Dursun O; Yilmaz A; Fidanci SB; Tamer L; Vatansever M; Ozer O; Dinc E
    Beyoglu Eye J; 2022; 7(3):188-192. PubMed ID: 36185984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LOXL1 expression in lens capsule tissue specimens from individuals with pseudoexfoliation syndrome and glaucoma.
    Khan TT; Li G; Navarro ID; Kastury RD; Zeil CJ; Semchyshyn TM; Moya FJ; Epstein DL; Gonzalez P; Challa P
    Mol Vis; 2010 Nov; 16():2236-41. PubMed ID: 21139690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Apelin and Asymmetric Dimethylarginine Levels in Patients With Exfoliation Syndrome or Exfoliative Glaucoma.
    Bezci Aygun F; Kocabeyoglu S; Irkec M; Dikmen ZG; Umaroglu MM; Konstas AGP
    J Glaucoma; 2020 Jul; 29(7):593-597. PubMed ID: 32287143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese.
    Ozaki M; Lee KY; Vithana EN; Yong VH; Thalamuthu A; Mizoguchi T; Venkatraman A; Aung T
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3976-80. PubMed ID: 18450598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exfoliation Syndrome and Exfoliation Glaucoma in the Navajo Nation.
    Patil A; Swiston C; Wallace RT; Paulson C; Conley ME; McCoy L; Chaya C; Wirostko B
    Vision (Basel); 2022 Oct; 6(4):. PubMed ID: 36278673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.